Kaipu Bio: The company has deployed 35 third-party medical laboratories in key provinces and cities across the country_ Oriental Fortune Network

Every time an AI Express is sent, an investor asks a question on the investor interactive platform: How much is the company’s latest nucleic acid detection capability for COVID-19 per day? How many mobile inspection devices are there currently?

　　Cap Bio(300639.SZ) said on the investor interaction platform on March 17 that the company has deployed 35 third-party medical laboratories in key provinces and cities across the country, including Hong Kong, Guangzhou, Beijing, Shanghai, Shenzhen, Wuhan, Zhengzhou and Xi’an. , Shenyang, Jinan, Taiyuan, Kunming, Chengdu, Chongqing, Guiyang, Changsha, Nanchang, Hefei, Fuzhou, Lanzhou, Nanjing, Shantou, Chaozhou, Hangzhou, Xiamen, Nanning, Shijiazhuang, Dalian, Qingdao, Haikou, etc. The third-party medical laboratory has obtained a medical institution practice license and is officially operating, and can carry out related medical inspection services. It is equipped with nearly 20 sets of mobile PCR square cabin laboratories and 6 sets of air membrane laboratories. The company continues to pay attention to the development of the epidemic situation in various parts of the country, actively integrates the resources and capabilities of the group, and fully supports the epidemic prevention and control work in various places with the detection mode of “medical testing laboratory + air membrane laboratory, square cabin laboratory”, and makes its own efforts for epidemic prevention and control. contribution.

(Article source: Daily Economic News)

Article source: Daily Economic News

Responsible editor: 3

Original title: Kaipu Bio: The company has deployed 35 third-party medical laboratories in key provinces and cities across the country